0
Skip to Content
Granata Bio
Home
About Us
Pipeline
News & Press
Contact
Join Us
Granata Bio
Home
About Us
Pipeline
News & Press
Contact
Join Us
Home
About Us
Pipeline
News & Press
Contact
Join Us
Skip to Videos
  • All |
  • Presentations |
  • ASRM LI Event Image (2).png
    • Presentations,
    • 11/19/25

    Anti-Müllerian Hormone (AMH) as a Therapeutic Target in Women’s Health.

    During a Spotlight Theater presentation at ASRM 2025, Dr. David Pépin discussed AMH's evolving role from biomarker to therapeutic agent.

Granata Bio is shaping the future of reproductive health by reimagining what’s possible to help build families. Founded in 2018, the company is dedicated to identifying, developing, and accelerating fertility treatments that expand therapeutic choices and enhance access.

Navigate

Contact Us

Home

About

info@granata.bio

LinkedIn

News & Press

Join Us

Privacy Policy

Instagram

Contact

©2025 Granata Bio Corporation